Sales of counterfeit drugs have intensified during the Corona transition. The WHO has warned in the case of fast growing fake drugs in India.
The business of counterfeit medicines is spreading fast in the country. WHO itself has said that fake drugs are being sold on a large scale in the name of Coronavirus in India.
He says that along with cheap chemical, very little chemical or medicines made without essential chemical, the business of expired medicines is also increasing. The business of counterfeit drugs has reached $ 30 billion in lower and middle income income countries, including India.
Cheap masks, gloves and fake sanitizers are being sold along with medicines.
Along with medicines, masks, gloves and sanitizers are also being sold in large quantities in counterfeiters. Sometimes big pharma companies make their medicines from small companies. If any defect is found in these drugs, then only the company that manufactured the drug was considered responsible, but now there is a provision for legal action against both the manufacturer and the marketing companies. This is expected to improve the quality of medicines sold in the country as it will encourage pharma companies to directly monitor the quality of medicines before being sold to patients.
Strong rules are necessary to crack down on fake drugs
The company that manufactures medicines from the third party should be responsible for their quality. The current law puts all responsibilities only on the manufacturer company. The Indian Pharmaceutical Alliance is an association of large domestic companies.
At the same time, some big officials associated with the pharmaceutical industry believe that this rule will be harmful for companies marketing third party drugs because it will also hold them responsible for mistakes that they did not make. But it is certain that a big market of fake drugs has been established in the country. Some clear rules have to be made to control it.
Nidhi Malviya is fun loving girl. She writes at NoobFeeds about various topics related to Finance, Technology, Business etc.